The cosmetic uses of Botulinum toxin type A. (Q33750159)

29 July 2017

1 reference

title

The cosmetic uses of Botulinum toxin type A. (English)

1 reference

29 July 2017

Benedetto AV

1

1 reference

PubMed ID

10517680

29 July 2017

language of work or name

1 reference

1 September 1999

1 reference

International Journal of Dermatology

29 July 2017

1 reference

29 July 2017

38

1 reference

29 July 2017

641-655

1 reference

29 July 2017

9

1 reference

The environment and skin aging

29 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

The action of botulinum toxin on the neuro-muscular junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Botulinum Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Double-blind study of botulinum toxin in spasmodic torticollis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Botulinum toxin treatment in spasmodic torticollis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Double-blind, placebo-controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Effects of botulinum toxin injections on speech in adductor spasmodic dysphonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Treatment of focal dystonias of the hand with botulinum toxin injections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Cervical dystonia: clinical findings and associated movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Hemifacial spasm treated with botulinum A toxin injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Botulinum toxin treatment of hemifacial spasm

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Treatment of spasticity with botulinum toxin: a double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Management of strabismus with botulinum A toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

History of the cosmetic use of Botulinum A exotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Botulinum A exotoxin use in clinical dermatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Therapeutic uses of botulinum toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Intrasphincteric botulinum toxin for the treatment of achalasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Botulinum toxin type A for facial rejuvenation. United States and United Kingdom perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Therapeutic botulinum type A toxin: factors affecting potency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Systemic toxicity of botulinum toxin by intramuscular injection in the monkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

The effects of botulinum toxin on the synthesis, storage and release of acetylcholine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Functional repair of motor endplates after botulinum neurotoxin type A poisoning: biphasic switch of synaptic activity between nerve sprouts and their parent terminals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Antitoxins and botulinum toxin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Response to botulinum toxin F in seronegative botulinum toxin A--resistant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Botulinum toxin. The Newport Beach experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Complications of botulinum A exotoxin for hyperfunctional lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Cosmetic denervation of the muscles of facial expression with botulinum toxin. A dose-response study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Botulinum A exotoxin for glabellar folds: a double-blind, placebo-controlled study with an electromyographic injection technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

The management of hyperfunctional facial lines with botulinum toxin. A collaborative study of 210 injection sites in 162 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Treatment of hyperfunctional lines of the face with botulinum toxin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Systemic effect of local botulinum toxin injections unmasks subclinical Lambert-Eaton myasthenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Drug therapy: Disorders of neuromuscular transmission caused by drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Botulinum neurotoxin A selectively cleaves the synaptic protein SNAP-25

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

Crystalline Preparation of Botulinum Toxin Type a (Botox): Degradation in Potency with Storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-4362.1999.00722.X

10.1046/J.1365-4362.1999.00722.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference

PubMed ID

10517680